Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with non-small cell lung cancer (a type of lung cancer), confirmed through a tissue or cell sample.
- People whose lung cancer is at stage III or stage IV (meaning it is advanced or has spread).
- People who are 18 years of age or older.
- People who have a general health and activity level rated between 0 and 2 on a standard medical scale, meaning they are able to carry out daily activities with little to no limitation (confirm with trial site).
- People who have already started a first course of treatment for advanced or spreading lung cancer, using chemotherapy, immunotherapy, a combination of radiation and chemotherapy, or a targeted therapy.
- People whose cancer responded to that first course of treatment with the disease staying stable or improving, as seen in the first scan taken within six months of starting treatment.
- People whose most recent scan (taken within 28 days before joining) shows the disease is still stable or better — this scan may be a CT scan, a PET/CT scan, or a brain MRI if cancer has spread to the brain.
- People who scored 6 or below on an initial assessment completed through a web-based application (confirm with trial site).
- People who have basic computer skills.
- People who have a Bank-ID (a Swedish electronic identification system) and access to the Swedish healthcare information service "1177 Vårdguiden."
- People who have given written agreement to take part in the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have brain metastases (cancer that has spread to the brain) that are causing active symptoms.
- People who are pregnant, breastfeeding, or planning to become pregnant.
- People who are under legal guardianship or are currently detained or deprived of their liberty.
- People who, due to mental capacity, unwillingness, or language barriers, would have difficulty understanding what taking part in the study involves.
- People whose other treatments or health conditions might, in the opinion of the trial doctor, affect the treatment or the study results.
- People who are currently taking part in another clinical study that involves an active intervention or treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gunnar L Wagenius, MD,PhD, Karolinska University Hospital
Phone: +46707715655
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.